⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1070145 | 1.00 | — | — | |
| SCHEMBL4777211 | 1.00 | — | — | |
| SCHEMBL9637160 | 1.00 | — | — | |
| SCHEMBL7673861 | 1.00 | — | — | |
| SCHEMBL386177 | 1.00 | — | — | |
| SCHEMBL3804023 | 0.89 | LMNA (0.42) | — | |
| SCHEMBL18423851 | 0.86 | SIRT2 (0.37) | — | |
| SCHEMBL5698597 | 0.84 | SIRT2 (0.36) | — | |
| SCHEMBL21353932 | 0.83 | SIRT2 (0.35) | — | |
| SCHEMBL9701164 | 0.82 | CPT2 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5698101-A | Hollow fiber membranes | MEMTEC LIMITED (AU) | 1997-12-16 | — | — | US | claimed |
| US-20240050573-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2024-02-15 | — | — | US | disclosed |
| US-11738087-B2 | Lymph directing prodrugs | MONASH UNIVERSITY (AU) | 2023-08-29 | — | — | US | disclosed |
| US-20220211664-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2022-07-07 | — | — | US | disclosed |
| US-11311512-B2 | Lymph directing prodrugs | MONASH UNIVERSITY (AU) | 2022-04-26 | — | — | US | disclosed |
| US-20190105299-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2019-04-11 | — | — | US | disclosed |
| US-20180243425-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2018-08-30 | — | — | US | disclosed |
| US-20170326103-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2017-11-16 | — | — | US | disclosed |
| EP-3180349-A1 | LYMPH DIRECTING PRODRUGS | Monash University (AU) | 2017-06-21 | — | — | EP | disclosed |
| EP-3027216-A1 | COMPOSITIONS AND PREPARATION METHODS OF LOW MELTING IONIC SALTS OF POORLY- WATER SOLUBLE DRUGS | MW Encap Limited (GB) | 2016-06-08 | — | — | EP | disclosed |
| WO-2016023082-A1 | LYMPH DIRECTING PRODRUGS | MONASH UNIVERSITY (AU) | 2016-02-18 | — | — | WO | disclosed |
| CN-101484149-B | There is the pharmaceutical dosage form of the separate layer of multilamellar | EVONIK ROHM GMBH (DE) | 2015-12-02 | — | — | CN | disclosed |
| WO-2015013772-A1 | COMPOSITIONS AND PREPARATION METHODS OF LOW MELTING IONIC SALTS OF POORLY- WATER SOLUBLE DRUGS | MONASH UNIVERSITY (AU) | 2015-02-05 | — | — | WO | disclosed |
| US-20110165110-A1 | Hair Conditioning Composition And Low Energy Method Of Producing The Same | SHISEIDO COMPANY, LTD. (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110135587-A1 | Hair Conditioning Composition | SHISEIDO COMPANY, LTD. (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2316414-A1 | HAIR CONDITIONER COMPOSITION | Shiseido Company, Ltd. (JP) | 2011-05-04 | — | — | EP | disclosed |
| US-5500217-A | MICROBIOCIDE FOR COSMETICS | ZENECA LIMITED (GB) | 1996-03-19 | — | — | US | disclosed |
| EP-0498636-B1 | Cosmetic composition | ZENECA LTD (GB) | 1995-09-06 | — | — | EP | disclosed |
| WO-1992013520-A1 | COMPOSITION | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-08-20 | — | — | WO | disclosed |
| EP-0498636-A1 | Cosmetic composition | ZENECA LIMITED (GB) | 1992-08-12 | — | — | EP | disclosed |